Stirling fishes for trout
Tuesday, 15 July, 2008
Stirling Products North America, a subsidiary of Perth's Stirling Products [ASX: STI] has demonstrated the results of its research into treatment of Loma microsporidial gill disease at an American Fisheries Society meeting.
Loma gill disease, caused by Loma salmonae, is an untreatable disease commonly found in farmed fish, particularly in Pacific salmon and trout.
Research conducted by Stirling demonstrates that the company's ProVale product was more effective at inhibiting Loma infection in rainbow trout when compared with unlicensed products.
ProVale is a beta glucan extract designed to stimulate the immune system.
Breast augmentation procedure uses 3D-printed scaffolds
3D-printed scaffold technology from medtech company BellaSeno has been used in a primary breast...
Victoria detects H5N1 avian influenza strain
It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
